Clinical Trial Update: 18F-DOPA-PET in Planning Surgery in Patients With Gliomas [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 18F-DOPA-PET imaging to aid surgical planning for malignant glioma and recurrent brain neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasm
• Malignant Glioma

Drugs mentioned

• 6-[18F]fluoro-L-DOPA (18F-DOPA) PET imaging agent (6-[18F]fluoro-L-DOPA)

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Glioma, Recurrent Brain Neoplasm | EARLY_Phase 1 | Status: COMPLETED